Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Apoptosis
Retinoblastoma plays a role in survival of Abl-dependent human tumor cells
March 24th, 2006
According to a study from Japan, retinoblastoma (Rb) plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl Tyr kinase. "The Rb gene product is a tumor suppressor that is mutated or inactivated in many types of human cancers. Although Rb is known to be an upstream negative regulator of Abl protein tyrosine kinase, we propose here that Rb also functions as a downstream effector of Abl that plays a positive role in survival of Abl-dependent human tumor cells, including Bcr/Abl-positive chronic myelogenous leukemia (CML)," wrote K. Nagano and colleagues, University of Tokyo. They continued, "We show that Rb is...
Source: Drug Week (2006-03-24)
|
